SVRA: Savara Corp Sotuvga nisbatan narx
Savara Inc. biologik vositalarni yallig'lanish joylariga maqsadli yetkazib berishni joriy etish orqali kamyob o'pka proteinozini davolashda ustunlikka intilmoqda. GURU.Markets portali ushbu P/S vaqtlar ketma-ketligini namoyish etadi, bunda metrik qiymati joriy daromad baholashini aks ettiradi. Kompaniya tijoratdan oldingi bosqichda bo'lganligi sababli, kelajakdagi narx dinamikasi bevosita yakuniy tartibga soluvchi qarorlarga bog'liq.
Savara Corp (SVRA) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Savara Inc.|SVRA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Savara Pharma|SVRA - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Savara Corp|SVRA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Savara|Oraliq qoplash koeffitsiyenti savarapharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
SVRA - Sof foyda|Kompaniya foydasi prognozi Savara Inc.|SVRA - Narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati Savara Inc|SVRA - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Savara Corp|SVRA - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Savara|SVRA - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik o'zgarishi savarapharma.com|SVRA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Savara Inc.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:savarapharma.com, SVRA
P/S koeffitsiyenti Savara Inc. (SVRA) bozor kapitalizatsiyasining yillik daromadiga nisbati sifatida hisoblanadi va bu investorlar nazarida bir dollar sotuvning qiymatini belgilaydi. Sotuvga nisbatan narx koeffitsiyentini tahlil qilish biofarmatsevtika logistika xarajatlarining samaradorligini baholash imkonini beradi, bunda klinikalarga yetkazib berishning barqarorligi aktivning fundamental chidamliligiga va joriy bozor baholashlarining asoslanganligiga bevosita ta'sir ko'rsatadi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|IMVT: P/S multiplikatori|kiniksa.com (KNSA) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati GRFS|Narxning daromadga nisbati ADPT|P/S multiplikatori CLDX|P/S multiplikatori Aurinia Corp (AUPH)|Narxning daromadga nisbati BioCryst BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Therapeutics, Inc. - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|Tourmaline - Bozor kapitallashuvining daromadga nisbati|PGEN (Precigen, Inc.) - P/S multiplikatori|pharming.com (PHAR) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Nektar Therapeutics Inc. (NKTR)|Upstream Bio, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|IMNM - Kapitalizatsiyaning daromadga nisbati|GOSS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti kalvista.com KALV|Septerna (SEPN) - Narxning daromadga nisbati|PVLA - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati RIGL|Narxning daromadga nisbati ANAB|Narxning daromadga nisbati Astria Therapeutics (ATXS)|ENGN (engene.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori RAPT (RAPT Therapeutics)|P/S multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS - Narxning daromadga nisbati|Narxning sotuvga nisbati KYTX|TLSA: P/S multiplikatori|cabalettabio.com - Bozor kapitallashuvining daromadga nisbati|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|P/S multiplikatori Theratechnologies, Inc.|Narxning daromadga nisbati Avalo Therapeutics Inc. (AVTX)|ELDN (Eledon Pharmaceuticals, Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Agenus AGEN|CLYM - Kapitalizatsiyaning daromadga nisbati|Zura Bio - P/S multiplikatori|ATYR - P/S multiplikatori|ADAG (adagene.com) - Kapitalizatsiyaning daromadga nisbati|Ikena Oncology - Bozor kapitallashuvining daromadga nisbati|STTK (Shattuck Labs Inc) - P/S multiplikatori|Equillium Bio (EQ) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Connect Biopharma (CNTB)|Kapitalizatsiyaning daromadga nisbati immunic-therapeutics.com IMUX|Narxning daromadga nisbati Atara Bio ATRA|IFRX - Kapitalizatsiyaning daromadga nisbati|XFOR: Kapitalizatsiyaning daromadga nisbati|ACET - P/S multiplikatori|celularity.com (CELU) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati INMB|BRNS (Barinthus Bio) - P/S multiplikatori|Sotuvga nisbatan narx Kezar Life Sciences Inc KZR|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|Narx/daromad koeffitsiyenti akaritx.com|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|P/S multiplikatori Q32 Bio Inc QTTB|GOVX: Kapitalizatsiyaning daromadga nisbati|EDSA: Narxning daromadga nisbati|IBIO: P/S multiplikatori|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|BOLT: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HCWB|P/S multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti XORTX Therapeutics Inc XRTX|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|INDP (Indaptus Therapeutics) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|Narx/daromad koeffitsiyenti affimed.com|Narxning daromadga nisbati Allakos ALLK|Narx/daromad koeffitsiyenti HOOKIPA Pharma, Inc. (HOOK)|IGMS: Kapitalizatsiyaning daromadga nisbati|ITOS: Narxning daromadga nisbati|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|TC BioPharm (Holdings) Plc - Bozor kapitallashuvining daromadga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
